We observed in all patients a cluster of variants that was clonal in both pre- and post-treatment biopsies (cancer cell fraction [CCF] around 1.0 on both x and y axis in S10 Fig); all gain-of-function PIK3CA and TP53 mutations, when present in the tumour, belonged to this cluster. This evidence concerns the gene PIK3CA and cancer.